SEC Form 4 · accession 0001104659-16-095144
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Yung-Cheng Chen
Director
Period of report
Feb 8, 2016
Accepted (ET)
Feb 9, 2016 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $2.43 | Feb 8, 2016 | A | 460,626 | A | — | Feb 8, 2026 | Ordinary Shares | 460,626 | 460,626 | D |
Explanation of responses
- F1These securities vest over a three-year period as follows: 1/3 of these securities become exercisable on each anniversary of February 8, 2016.